Polymorphisms in MBOAT7, PNPLA3, GSTT1, TM6SF2, and HSD17B13 are associated with hepatic fat accumulation and inflammation, predisposing individuals to cirrhosis and HCC [27,28]. Here, PNPLA3 is linked to hepatocellular carcinoma.